Cancer Non-Hodgkin Lymphoma

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Non-Hodgkin Lymphoma Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Non-Hodgkin Lymphoma Projects
--Bayer HealthCare Pharmaceuticals
--erly Berlex, Inc.)
--Allos Therapeutics Inc
--Biogen Idec Inc
--Bayer Schering Pharma AG
--Cell Therapeutics Inc
--Celgene Corporation
--Eisai Co Ltd
--Cephalon Inc
--Favrille Inc
--Eli Lilly & Co
--Genmab A/S
--Genentech Inc
--GlaxoSmithKline plc
--Genta Incorporated
--Johnson & Johnson
--Immunomedics Inc
--Pharmacyclics Inc
--Millennium Pharmaceuticals Inc
--Wyeth
--Seattle Genetics Inc

--Top Companies in early stage Non-Hodgkin Lymphoma Projects
--Affimed Therapeutics AG
--Abiogen Pharma S.p.A.
--AstraZeneca Plc
--Alfacell Corp
--Cephalon Inc
--Boehringer Ingelheim GmbH
--Genentech Inc
--Enzon Pharmaceuticals Inc
--Immunomedics Inc
--ImmunoGen Inc
--INTRACEL Corp
--Innate Pharma S.A.
--ProNAi Therapeutics, Inc.
--Kyowa Hakko Kogyo Co., Ltd.
--Symbigene
--Sanofi-Aventis
--Wyeth
--VGX Pharmaceuticals, Inc
--ZymoGenetics Inc
--Zenotech Laboratories Ltd.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View